Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 may be associated with long-term adverse effects such as cytopenia and immune deficiency. In order to characterize these late events, we analyzed 31 patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene cilo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Haematologica (Roma) Jg. 106; H. 10; S. 2667 - 2672
Hauptverfasser:	Strati, Paolo, Varma, Ankur, Adkins, Sherry, Nastoupil, Loretta J, Westin, Jason, Hagemeister, Fredrick B, Fowler, Nathan H, Lee, Hun J, Fayad, Luis E, Samaniego, Felipe, Ahmed, Sairah, Chen, Yiming, Horowitz, Sandra, Arafat, Sara, Johncy, Swapna, Kebriaei, Partow, Mulanovich, Victor Eduardo, Ariza Heredia, Ella, Neelapu, Sattva S
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Italy Fondazione Ferrata Storti 01.10.2021 Ferrata Storti Foundation
Schlagworte:	Antigens, CD19 Biological Products Humans Immune Reconstitution Immunotherapy, Adoptive Lymphoma, Large B-Cell, Diffuse - drug therapy Neutropenia
ISSN:	0390-6078, 1592-8721, 1592-8721
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!